Benzazepine derivatives for the treatment of neurological disorders

Details for Australian Patent Application No. 2003294909 (hide)

Owner Glaxo Group Limited

Inventors Bamford, Mark James; Sehmi, Sanjeet Singh; Witherington, Jason; Wilson, David Matthew; Dean, David Kenneth

Agent Davies Collison Cave

Pub. Number AU-B-2003294909

PCT Number PCT/EP2003/0145

PCT Pub. Number WO2004/056369

Priority 0229820.6 20.12.02 GB; 0312607.5 02.06.03 GB

Filing date 18 December 2003

Wipo publication date 14 July 2004

Acceptance publication date 17 May 2007

International Classifications

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

22 April 2004 Complete Application Filed

  Priority application(s): 0229820.6 20.12.02 GB; 0312607.5 02.06.03 GB

19 August 2004 Application Open to Public Inspection

  Published as AU-B-2003294909

17 May 2007 Amendment Made

  The nature of the amendment is: Amend the invention title to read Benzazepine derivatives for the treatment of neurological disorders

17 May 2007 Application Accepted

  Published as AU-B-2003294909

13 September 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003294910-PROBE FOR AN OPTICAL NEAR FIELD MICROSCOPE WITH IMPROVED SCATTERED LIGHT SUPPRESSION AND METHOD FOR PRODUCING THE SAME

2003294908-Novel food production process